Mrna-modified fus/nrf2 signalling inhibits ferroptosis and promotes prostate cancer growth

HIGHLIGHTS

  • who: Signalling Inhibits Ferroptosis and collaborators from the Department of Urology, The First People's Hospital Affiliated to Huzhou Normal College, Huzhou, China have published the research work: mRNA-Modified FUS/NRF2 Signalling Inhibits Ferroptosis and Promotes Prostate Cancer Growth, in the Journal: Computational and Mathematical Methods in Medicine of 27/04/2022
  • what: Regarding the imperfect mechanism of occurrence and development of adenocarcinoma (PRAD) this study investigated mRNA-modified FUS/NRF2 to inhibit and promote adenocarcinoma Methods. This study shows that FUS is highly expressed in PRAD and CRPC, and low expression FUS PRAD . . .

     

    Logo ScioWire Beta black

    If you want to have access to all the content you need to log in!

    Thanks :)

    If you don't have an account, you can create one here.

     

Scroll to Top

Add A Knowledge Base Question !

+ = Verify Human or Spambot ?